Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K DeLong

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Antisense & Nucleic Acid Drug Development|January 1, 1996
Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonatesR K Delong, P S Miller
Journal of Nanoscience and Nanotechnology|October 20, 2006
R4 peptide-pDNA nanoparticle coated HepB vaccine microparticles: sedimentation, partitioning, and spray freeze dry bioprocessesR Knowle, A Werner, R K DeLong
Biochemical and Biophysical Research Communications|June 5, 2004
pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analysesP Medberry, S Dennis, T Van Hecke, et al.
Nucleic Acids Research|February 15, 1996
Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenineP S Miller, G Bi, S A Kipp, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Challenges and potential for RNA nanoparticles (RNPs)D Davis, U Akhtar, B Keaster, et al.
Journal of Molecular Recognition : JMR|March 1, 1997
Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistriesX Cheng, R K DeLong, E Wickstrom, et al.
Pharmaceutical Research|April 1, 1997
Hepatic distribution and clearance of antisense oligonucleotides in the isolated perfused rat liverA Nolting, R K DeLong, M H Fisher, et al.
Antisense & Nucleic Acid Drug Development|April 1, 1997
Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude miceR K DeLong, A Nolting, M Fisher, et al.
Journal of Biomedical Nanotechnology|May 27, 2010
Interaction of MnO and ZnO nanomaterials with biomedically important proteins and cellsH Gann, G Glaspell, R Garrad, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2019
Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic CancerR K DeLong, Yi-Hsien Cheng, Paige Pearson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Antisense & Nucleic Acid Drug Development|January 1, 1996
Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonatesR K Delong, P S Miller
Journal of Nanoscience and Nanotechnology|October 20, 2006
R4 peptide-pDNA nanoparticle coated HepB vaccine microparticles: sedimentation, partitioning, and spray freeze dry bioprocessesR Knowle, A Werner, R K DeLong
Biochemical and Biophysical Research Communications|June 5, 2004
pDNA bioparticles: comparative heterogeneity, surface, binding, and activity analysesP Medberry, S Dennis, T Van Hecke, et al.
Nucleic Acids Research|February 15, 1996
Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenineP S Miller, G Bi, S A Kipp, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Challenges and potential for RNA nanoparticles (RNPs)D Davis, U Akhtar, B Keaster, et al.
Journal of Molecular Recognition : JMR|March 1, 1997
Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistriesX Cheng, R K DeLong, E Wickstrom, et al.
Pharmaceutical Research|April 1, 1997
Hepatic distribution and clearance of antisense oligonucleotides in the isolated perfused rat liverA Nolting, R K DeLong, M H Fisher, et al.
Antisense & Nucleic Acid Drug Development|April 1, 1997
Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude miceR K DeLong, A Nolting, M Fisher, et al.
Journal of Biomedical Nanotechnology|May 27, 2010
Interaction of MnO and ZnO nanomaterials with biomedically important proteins and cellsH Gann, G Glaspell, R Garrad, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2019
Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic CancerR K DeLong, Yi-Hsien Cheng, Paige Pearson, et al.
Pageof 2